Anixa Biosciences’ (ANIX) “Buy” Rating Reiterated at D. Boral Capital
D. Boral Capital restated their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a report released on Wednesday,Benzinga reports. They currently have a $10.00 price objective on the stock. A number of other research analysts have also commented on the company. HC Wainwright reiterated a “buy” rating and set a $7.00 […]
D. Boral Capital restated their buy rating on shares of Anixa Biosciences (NASDAQ:ANIX – Free Report) in a report released on Wednesday,Benzinga reports. They currently have a $10.00 price objective on the stock. A number of other research analysts have also commented on the company. HC Wainwright reiterated a “buy” rating and set a $7.00 […]
